From: Impact of the faecal immunochemical test on colorectal cancer survival
UNIVARIATE ANALYSIS | MULTIVARIATE ANALYSIS | ||||
---|---|---|---|---|---|
EARLY STAGE (I, II) N = 711 N (%) | ADVANCED STAGE (III, IV) N = 814 N (%) | p | OR | 95% CI | |
GROUP a | |||||
Group 1 | 143 (51.3) | 136 (48.7) | 0.08 | 1 | |
Group 2 | 568 (45.5) | 678 (54.5) | 1.28 | 0.98–1.70 | |
AGE (years) | |||||
≤ 49 | 33 (45.8) | 39 (54.2) | 1 | ||
50–69 | 244 (49.9) | 245 (50.1) | 0.19 | 0.86 | 0.52–1.43 |
≥ 70 | 434 (45.0) | 530 (55.0) | 1.07 | 0.66–1.74 | |
SITES | |||||
Rectum | 174 (47.4) | 193 (52.6) | |||
Distal colon | 310 (45.7) | 368 (54.3) | 0.71 | – | – |
Proximal colon | 220 (48.1) | 237 (51.9) | |||
Unknown | 7(30.4) | 16(69.6) | |||
HISTOLOGY | |||||
Adenocarcinoma | 683 (47.1) | 766 (52.9) | 1 | 0.64–2.04 | |
Mucinous adenocarcinoma | 21 (43.7) | 27 (56.3) | 0.06 | 1.14 | 1.15–6.46 |
Othersb | 7 (25.0) | 21 (75.0) | 2.72 |